Skip to results
Modify your search
NARROW
1-20 of 51
Authors: Eric Burton
Journal Article
Implications of sociodemographic and clinical factors on symptom burden: Age-specific survivorship care in the primary central nervous system tumor population Get access
Neuro-Oncology Practice, npae116, https://doi.org/10.1093/nop/npae116
Published: 26 November 2024
Journal Article
CTIM-03. IMMUNE CHECKPOINT INHIBITOR NIVOLUMAB IN PEOPLE WITH RECURRENT SELECT RARE CNS CANCERS: RESULTS OF INTERIM ANALYSIS IN A NON-HEAVILY PRETREATED COHORT
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii85, https://doi.org/10.1093/neuonc/noae165.0337
Published: 11 November 2024
Journal Article
The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendations
Neuro-Oncology Practice, Volume 12, Issue 1, February 2025, Pages 76–86, https://doi.org/10.1093/nop/npae067
Published: 19 July 2024
Journal Article
Assessing sleep in primary brain tumor patients using smart wearables and patient-reported data: Feasibility and interim analysis of an observational study Get access
Neuro-Oncology Practice, Volume 11, Issue 5, October 2024, Pages 640–651, https://doi.org/10.1093/nop/npae048
Published: 24 May 2024
Journal Article
Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findings
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae019, https://doi.org/10.1093/noajnl/vdae019
Published: 08 February 2024
Journal Article
CSIG-23. PRIMARY CILIA DISRUPTION ALTERS THE TRANSCRITOME OF HUMAN GLIOBLASTOMA CELLS AND SUGGESTS NOVEL THERAPEUTIC STRATEGIES
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v45, https://doi.org/10.1093/neuonc/noad179.0179
Published: 10 November 2023
Journal Article
Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clustering
Neuro-Oncology Advances, Volume 5, Issue 1, January-December 2023, vdac188, https://doi.org/10.1093/noajnl/vdac188
Published: 26 December 2022
Journal Article
INNV-32. COMPARING THE MONTREAL COGNITIVE ASSESSMENT (MOCA) FULL AND 5-MINUTE PROTOCOLS IN MILD COGNITIVE IMPAIRMENT SCREENING OF ADULT CNS TUMOR PATIENTS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii148, https://doi.org/10.1093/neuonc/noac209.572
Published: 14 November 2022
Journal Article
NCOG-40. UTILITY OF THE SEIZURE CONTROL COMPOSITE INDEX (RANO-SCCI) IN EVALUATING SEIZURES IN CNS TUMOR PATIENTS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii206, https://doi.org/10.1093/neuonc/noac209.791
Published: 14 November 2022
Journal Article
NCOG-39. DISCOVERY OF CLINICAL AND DEMOGRAPHIC DETERMINANTS OF SYMPTOM BURDEN IN PRIMARY BRAIN TUMOR PATIENTS USING NETWORK ANALYSIS AND UNSUPERVISED CLUSTERING
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii205–vii206, https://doi.org/10.1093/neuonc/noac209.790
Published: 14 November 2022
Journal Article
INNV-25. ASSESSING SLEEP AND CIRCADIAN RHYTHMS IN PRIMARY BRAIN TUMORS PATIENTS: AN OBSERVATIONAL STUDY
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii146–vii147, https://doi.org/10.1093/neuonc/noac209.565
Published: 14 November 2022
Journal Article
INNV-21. FEASIBILITY OF A VIRTUAL REALITY (VR) INTERVENTION TARGETING DISTRESS AND ANXIETY IN PRIMARY BRAIN TUMOR (PBT) PATIENTS AT THE TIME OF NEUROIMAGING: INTERIM ANALYSIS OF A PHASE 2 CLINICAL TRIAL
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii145–vii146, https://doi.org/10.1093/neuonc/noac209.561
Published: 14 November 2022
Journal Article
BIOM-46. EXPLORING CLINICAL AND PATHOLOGIC CHARACTERISTICS IN GLIOBLASTOMA LONG -TERM SURVIVORS (LTS) VERSUS SHORT-TERM SURVIVORS (STS)
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii14–vii15, https://doi.org/10.1093/neuonc/noac209.056
Published: 14 November 2022
Journal Article
NIMG-101. COMPARISON OF PRE-SURGICAL MRI FINDINGS FROM LONG-TERM (≥ 3 YRS) VERSUS SHORT-TERM (< 3 YRS) GLIOBLASTOMA SURVIVORS: A BLINDED, CASE-CONTROL REVIEW
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii188, https://doi.org/10.1093/neuonc/noac209.719
Published: 14 November 2022
Journal Article
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients
Neuro-Oncology Practice, Volume 9, Issue 6, December 2022, Pages 526–535, https://doi.org/10.1093/nop/npac049
Published: 22 June 2022
Journal Article
The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments
Neuro-Oncology Practice, Volume 9, Issue 5, October 2022, Pages 429–440, https://doi.org/10.1093/nop/npac038
Published: 14 May 2022
Journal Article
QOLP-33. EVIDENCE OF FINANCIAL TOXICITY IN PRIMARY CENTRAL NERVOUS SYSTEM TUMOR PATIENTS: CORRELATIONS BETWEEN EMPLOYMENT STATUS, SYMPTOM BURDEN AND HEALTH-RELATED QUALITY OF LIFE
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi190, https://doi.org/10.1093/neuonc/noab196.753
Published: 12 November 2021
Journal Article
NCOG-34. A DESCRIPTIVE ANALYSIS OF GLIOMATOSIS CEREBRI CASES, COMPARED ACCORDING TO IDH STATUS
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi159, https://doi.org/10.1093/neuonc/noab196.624
Published: 12 November 2021
Journal Article
NCOG-39. EXPLORING PATIENT REPORTED OUTCOMES (PROS) ACROSS ETHNORACIAL GROUPS IN PRIMARY BRAIN TUMOR (PBT) PATIENTS: DIFFERENCES IN THE ILLNESS EXPERIENCE
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi160, https://doi.org/10.1093/neuonc/noab196.629
Published: 12 November 2021
Journal Article
NCOG-47. CONGRUENCE BETWEEN PROVIDER REPORTED PERFORMANCE STATUS AND BOTH OBJECTIVE AND PERCEIVED COGNITION IN A GLIOMA POPULATION
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi162, https://doi.org/10.1093/neuonc/noab196.636
Published: 12 November 2021
